Search results

• Our strategy

  Our focus on innovation, sustainability and growth ensures that Croda smart science helps our customers meet their own sustainability targets as well as consumer demands.

• Procurement and sustainable sourcing

  Using natural resources brings a responsibility to ensure no associated negative social or environmental impacts, and an opportunity to advocate and contribute to positive change.

• Ethics

  Responsible and ethical behaviour is fundamental to the way we operate at Croda.

• Megatrends

  Trends which will influence market demand and growth at Croda, Providing new opportunities and shaping our approach.

• Our Fundamentals

  We will consider all stakeholders in our ecosystem and adopt best practices in environment, labour and human rights, ethics and sustainable procurement.

• Nature Positive

  By 2030, we will be Nature Positive.

• Safety

  Behavioural and process safety are extremely important for us at Croda, the safety of our employees and neighbours is of paramount importance.

• Governance

  Our Board are responsible for good governance and are committed to the highest standards of corporate governance.

• Policies and procedures

  We operate a range of policies covering all area of our Business to uphold the principles of socially responsible business practices.

• New frontiers in fragrance and flavours

  Croda acquired international fragrances and flavours company Iberchem in 2020, the largest acquisition in our history and a major move into a market strongly aligned with our business.

• Modern slavery

  The Modern Slavery Act was introduced in 2015. It requires larger businesses to report annually the steps that they are taking to reduce the risk of slavery and human trafficking taking place within their supply chains or in any part of their businesses. Read Croda's statement here.

• Our targets

  We are developing our sustainability strategy to 2030, ensuring our alignment to the United Nations Sustainable Development Goals (SDGs).

• Leadership

  Our Board and Executive Committee provide leadership in delivering for our customers and achieving our strategic priorities.

• India

  Croda India's manufacturing site was founded in 1995 and is located at Navi Mumbai.

• Greater China

  Croda has been present in China since 1993.

• Singapore

  Croda Singapore was founded in 1986 and is the regional headquarters of the Asia Pacific region.

• Croda named Britain’s Most Admired Chemicals Company for the tenth time, extending an exceptional record of sustained peer recognition

  20 January 2026: Croda International Plc has been named Britain’s Most Admired Chemicals Company for the tenth time, highlighting its leadership in smart science and high-performance ingredients.

• Croda at a glance

  At Croda, we are driven by our Purpose, to use smart science to create high-performance ingredients and technologies that improve lives.

• Croda acquired crop enhancement company Plant Impact

  Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Croda acquires marine biotechnology specialists Nautilus

  World class scientists, focusing on using marine microbial biodiversity to discover novel actives and materials for applications across all Croda market sectors.

• Environmental, Social and Governance (ESG)

  Useful links to further information on our environmental, governance and social impact.

• Ratings and frameworks

  View our ratings and frameworks which help to shape our sustainability programme.

• Sustainability

  Sustainability spans every area of our business and is a crucial way we add value to our customers.

• Investor seminar on our sustainability strategy

  20 October 2020: Steve Foots, CEO and other senior members of our management team provided a comprehensive overview of our 2030 sustainability Commitment.

• Our Values

  At Croda, our company core values of Responsible, Innovative, and Together are at the heart of how we operate, shaping a unique, collaborative culture that supports our Purpose.

• Behind the Science

  Discover how Croda’s high-quality ingredients, scientific expertise and sustainable innovation deliver end-to-end solutions that power growth across Consumer Care and Life Sciences.

• Meet the expert: Dhanila Varkey, Applications Team Lead

  Discover how Croda’s applications expert Dhanila Varkey is using nanotechnology to improve targeting, absorption and effectiveness in topical and transdermal drug delivery.

• Meet the expert: Will Small, Research & Technology Specialist

  Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.

• Meet the expert: Chris Wells, Applications Team Lead

  Meet the expert: Chris Wells, Applications Team Lead

• Your ingredients partner powering health innovation

  Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.

• Sustainability Impact Report 2024

  Find our 2024 Sustainability Impact Report here

• Steve Foots, CEO Sustainability Statement 2024

  One of our core philosophies is to take a leadership position in sustainability and innovation in our chosen markets.

• Materiality assessment

  Our Materiality Assessment performed a comprehensive value chain assessment, and identified areas of transformative action within the business

• Sustainability Report archive

  View our sustainability report archives.

• Croda acquires innovative seed enhancement company Incotec

  Operating in one of the fastest growing segments within the crop care market, Incotec develop and supply a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops.

• Acquisition of Iberchem expands reach into high growth fragrances market

  Acquiring the entire issued share capital of Fragrance Spanish Topco, S.L., trading as Iberchem (“the acquisition”), a leading global fragrances and flavours (“F&F”) company.

• Strengthening Life Sciences with the acquisition of Avanti Polar Lipids

  A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.

• Strategic investment Entekno Materials

  A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Vietnam

  Croda’s Vietnam office was founded in 2012 and is located in Ho Chi Minh City.

• Sustainability Committee

  Responsible for global Group-wide engagement with our sustainability targets and providing guidance and support to sites, regions and sectors to develop plans to deliver our sustainability goals.

• Annual Report archive

  Annual reports from previous years.

• Brazil

  Croda do Brasil was established in 1974 and the Campinas manufacturing site in 1977.

• Mexico

  In 1977, a joint venture company was formed in Mexico, Quimica Croda SA.

• Croda Half Year Results fireside chat with Morgan Stanley

  Watch our fireside chat with Morgan Stanley from 29 July 2025.

• PTIC divestment

  View the full webinar from the 22 December 2021 discussing the agreement to divest the majority of our PTIC businesses to Cargill Inc.

• Third quarter trading update

  Update on trading from 01 July to 30 September 2023

• Half year 2024 results

  Group performance in line with expectations reflecting more stable market conditions and operational progress

• UK Government to support expansion of Croda's lipid systems manufacturing facility

  31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.